BIO: fed cancer funding good, but more needed.(Friday, Feb. 27)

While the more than $6 billion increase in President Obama's fiscal year 2010 budget proposal for cancer research is a positive step in finding new cures, that progress could be for naught if Congress fails to give biotech companies--which are involved in developing and advancing more than 250 investigational cancer products--tax breaks and other needed help to survive the economic downturn, said Jim Greenwood, CEO of the Biotechnology Industry Organization (BIO). With the release Thursday of the president's $3.55 trillion 2010 budget--which includes $76.8 billion for the Department of Health and Human Services and a proposal for a $634 billion reserve fund to help finance health care …